Carmen Navia
About Carmen Navia
Carmen Navia is a Research Associate II at Integral Molecular, where she has worked since 2019. She previously held positions at Franklin & Marshall College and Children's Hospital of Philadelphia, focusing on antibody specificity and research related to colon cancer and SARS-CoV-2.
Work at Integral Molecular
Carmen Navia serves as a Research Associate II at Integral Molecular, a position held since 2019. In this role, she manages client samples utilizing the proprietary Membrane Protein Array (MPA) technology. This work focuses on understanding antibody specificity, which is critical for various applications in biomedical research and therapeutic development.
Previous Experience at Franklin & Marshall College
Before joining Integral Molecular, Carmen Navia worked as a Laboratory Technician in Colon Cancer Biology at Franklin & Marshall College from 2014 to 2018. During her four years in this position, she gained valuable experience in laboratory techniques and research methodologies relevant to cancer biology.
Experience at Children's Hospital of Philadelphia
Carmen Navia held the position of Research Technician at Children's Hospital of Philadelphia for seven months in 2018 to 2019. This role allowed her to further develop her research skills in a clinical setting, contributing to projects that supported pediatric health and disease research.
Education and Expertise
Carmen Navia earned her Bachelor’s Degree in Biochemistry and Molecular Biology from Franklin & Marshall College, completing her studies from 2014 to 2018. This educational background provided her with a strong foundation in biochemical principles and molecular techniques, which she applies in her current research.
Research on SARS-CoV-2 Antibodies
During the COVID-19 pandemic, Carmen Navia worked with antibodies against the SARS-CoV-2 virus. This experience contributed to her expertise in antibody research and its implications for public health, particularly in understanding immune responses to viral infections.